Ricochet is the best place on the internet to discuss the issues of the day, either through commenting on posts or writing your own for our active and dynamic community in a fully moderated environment. In addition, the Ricochet Audio Network offers over 50 original podcasts with new episodes released every day.
[Member Post]
A hospital in Paris just announced “statistically significant clinical improvement” in Covid-19 patients using a drug called tocilizumab (aka Actemra). Tocilizumab is a monoclonal antibody that targets the IL-6 receptor, which is a signaling molecule in the immune system. In other words, the drug actually inhibits a specific part of the immune response, in this […]
⚠️ This is a members-only post on Ricochet's Member Feed. Want to read it? Join Ricochet's community of conservatives and be part of the conversation.
Join Ricochet for free.
There is 1 comment.
But you can't read it because you're not signed in!